Skip navigation

Main menu

  • What's on
  • Art & Artists
    • The Collection
      Artists
      Artworks
      Art by theme
      Media
      Videos
      Podcasts
      Short articles
      Learning
      Schools
      Art Terms
      Tate Research
      Art Making
      Create like an artist
      Kids art activities
      Tate Draw game
  • Visit
  • Shop
Become a Member
  • DISCOVER ART
  • ARTISTS A-Z
  • ARTWORK SEARCH
  • ART BY THEME
  • VIDEOS
  • ART TERMS
  • SCHOOLS
  • TATE KIDS
  • RESEARCH
  • Tate Britain
    Tate Britain Free admission
  • Tate Modern
    Tate Modern Free admission
  • Tate Liverpool + RIBA North
    Tate Liverpool + RIBA North Free admission
  • Tate St Ives
    Tate St Ives Ticket or membership card required
  • FAMILIES
  • ACCESSIBILITY
  • SCHOOLS
  • PRIVATE TOURS
Tate Logo
Become a Member

GlaxoSmithKline (Middlesex, UK)

Biography

GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with headquarters in London. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.

GSK is the tenth largest pharmaceutical company and No. 294 on the 2022 Fortune Global 500, ranked behind other pharmaceutical companies China Resources, Sinopharm, Johnson & Johnson, Pfizer, Roche, AbbVie, Novartis, Bayer, and Merck Sharp & Dohme.

The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index. As of February 2024, it had a market capitalisation of £69 billion, the eighth largest on the London Stock Exchange.

The company developed the first malaria vaccine, RTS,S, which it said in 2014, it would make available for five per cent above cost. Legacy products developed at GSK include several listed in the World Health Organization's List of Essential Medicines, such as amoxicillin, mercaptopurine, pyrimethamine and zidovudine.

In 2012, under prosecution by the United States Department of Justice (DoJ) based on combined investigations of the Department of Health and Human Services (HHS-OIG), FDA and FBI, primarily concerning sales and marketing of the drugs Avandia, Paxil and Wellbutrin, GSK pleaded guilty to promotion of drugs for unapproved uses, failure to report safety data and kickbacks to physicians in the United States and agreed to pay a US$3 billion (£1.9bn) settlement. It was the largest health-care fraud case to date in the US and the largest settlement in the pharmaceutical industry.

This biography is from Wikipedia under an Attribution-ShareAlike Creative Commons License. Spotted a problem? Let us know.

Read full Wikipedia entry
Artwork
Close

Join in

  • Twitter
  • Facebook
  • YouTube
  • Instagram
  • Pinterest
Sign up to emails

Sign up to emails

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tate’s privacy policy

About

  • About us
  • Our collection
  • Terms and copyright
  • Governance
  • Picture library
  • ARTIST ROOMS
  • Tate Kids

Support

  • Tate Collective
  • Members
  • Patrons
  • Donate
  • Corporate
  • My account
  • Press
  • Jobs
  • Accessibility
  • Privacy
  • Cookies
  • Contact
© The Board of Trustees of the Tate Gallery, 2025
All rights reserved